CD19-directed CAR T cells therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19-directed CAR T cells therapy, covering 2018-12-03 to 2018-12-03. Get the full timeline:
Most recent: Clinical Trial Update: CD19-directed CAR T Cells Therapy in Relapsed/Refractory B Cell Malignancy [Phase 1, Phase 2]